07/09/2024 | Press release | Archived content
US BioTek is a Shoreline, Washington based Clinical Laboratory Improvement Amendments ("CLIA") and CAP accredited testing facility that provides a variety of immunology and chemistry profiles to clinicians worldwide. With over 30 years' experience in enzyme-linked immunosorbent assay technology, its dedicated team of experienced scientists and technicians utilize the latest research and technologies. "We were excited to support US BioTek's acquisition of RTL. The addition of the RTL platform expands the Company's specialized offering by adding testing for and identifying hazardous mold, toxins, and infectious diseases," said Dan Delgadillo, Managing Director of Northwest Sponsor Finance.
Northwest Sponsor Finance, with offices in Chicago and Columbus, Ohio, provides senior secured cash flow loans to private equity-backed lower middle market companies throughout the United States. Northwest Sponsor Finance offers products that support the acquisition, recapitalization and growth investment efforts of private equity firms operating in the lower middle market and focuses on companies that generate EBITDA between $2 million and $10 million. Northwest Sponsor Finance is a generalist group concentrating on asset lite business models in the business and consumer services, consumer products, asset-lite manufacturing, and value-added distribution sectors.
Based in Seattle, Washington Pike Street Capital invests in middle market companies with leading market positions, strong management teams, and discernible growth drivers. The firm targets sectors serving professional customers and B2B growth where it has extensive investing and operating experience, including test and measurement, industrial technology, specialty manufacturing, distribution & logistics, and business services. Pike Street Capital was co-founded by Paul Caragher, Dave Dandel and Ed Whatley. More information is available at www.pikestreetcapital.com.